TY  - JOUR

T1  - Cardiopulmonary exercise testing of patients with metastatic castrate-resistant prostate cancer as screening for vigorous exercise medicine prescription.

JO  - JCO Global Oncology

UR  - http://dx.doi.org/10.1200/go.2023.9.supplement_1.80

PY  - 2023/08/01

AU  - Newton RU

AU  - Hart NH

AU  - Kenfield SA

AU  - Galvao DA

AU  - Courneya KS

AU  - Ryan CM

AU  - Chan JM

AU  - Catto JWF

AU  - Winters-Stone KM

AU  - Van Hemelrijck M

AU  - Wylie H et al

ED  - 

DO  - DOI: 10.1200/go.2023.9.supplement_1.80

PB  - American Society of Clinical Oncology (ASCO)

VL  - 9

IS  - Supplement_1

SP  - 80

EP  - 80

Y2  - 2024/12/22

ER  -